Radius Health Announces Fourth Quarter and Full-Year 2019 Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Radius Health (RDUS) Tops Q4 EPS by 48c, Revenues Beat; Offers FY20 Revenue Guidance Below Consensus
February 27, 2020 7:34 AM ESTRadius Health (NASDAQ: RDUS) reported Q4 EPS of ($0.29), $0.48 better than the analyst estimate of ($0.77). Revenue for the quarter came in at $55.67 million versus the consensus estimate of $53.29 million.
I am very pleased that TYMLOS exited 2019 with a December majority share of postmenopausal osteoporosis... More
